Loading clinical trials...
Loading clinical trials...
S9624: Phase II Study of Ifosfamide in Patients With Aggressive Meningeal Tumors
Conditions
Interventions
ifosfamide
Locations
70
United States
CCOP - Scottsdale Oncology Program
Scottsdale, Arizona, United States
City of Hope Comprehensive Cancer Center
Duarte, California, United States
Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
Stanford University Medical Center
Stanford, California, United States
CCOP - Colorado Cancer Research Program, Incorporated
Denver, Colorado, United States
CCOP - Christiana Care Health Services
Newark, Delaware, United States
Start Date
July 1, 1998
Primary Completion Date
January 1, 2004
Completion Date
January 1, 2004
Last Updated
November 8, 2013
NCT05039801
NCT04055220
NCT06387485
NCT04832620
NCT05836571
NCT03449108
Lead Sponsor
SWOG Cancer Research Network
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions